Patents by Inventor Nabil J. Alkayed

Nabil J. Alkayed has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20210223269
    Abstract: The present disclosure provides biomarkers for the detection of coronary artery disease. The biomarkers comprise oxylipins and the detection, identification, and quantification can provide a means to diagnose, prognose, and manage subject at risk for cardiovascular disease. Methods of also provided for the detection and quantification of the oxylipins, for treating, and for predicting the survival of a subject at high risk for coronary artery disease.
    Type: Application
    Filed: January 22, 2021
    Publication date: July 22, 2021
    Applicants: Oregon State University, Oregon Health & Science University
    Inventors: Manuel Garcia-Jaramillo Rodriguez, Gerd Bobe, Claudia Susanne Maier, Donald Bradley Jump, Armando Alcázar-Magaña, Dai-Trang Elizabeth Le, Sanjiv Kaul, Nabil J. Alkayed
  • Patent number: 10912850
    Abstract: Radiofluorinated FNDP for PET imaging of soluble epoxide hydrolase (sEH) and method of using the same are disclosed.
    Type: Grant
    Filed: May 4, 2017
    Date of Patent: February 9, 2021
    Assignees: The Johns Hopkins University, Oregon Health & Science University
    Inventors: Andrew Horti, Martin G. Pomper, Nabil J. Alkayed
  • Publication number: 20090069418
    Abstract: Methods and compositions for the treatment of conditions associated with improper vasodilation are provided.
    Type: Application
    Filed: April 25, 2008
    Publication date: March 12, 2009
    Inventors: Nabil J. Alkayed, Jeffrey J. Iliff, Wenri Zhang, Michael Hutchens, Matthias J. Merkel, Donna M. Van Winkle